Cardiology

Patients in the Optimal Hospital wing are given iPads that let them access their medical records, see their care team, and view the schedule of their upcoming tests.

New features include wireless vital monitors, red lighting for nighttime, and surfaces and linens infused with antimicrobial copper.

Ochsner Medical Center's innovative Optimal Hospital initiative has sought to reduce hospital-acquired infections, length of stay, and readmissions.

Investigators evaluated whether volatile anesthetics would translate into better survivability in patients undergoing coronary artery bypass grafting.

Investigators found readmission risk was 4 times greater in patients with stays of 2 days or less.

A new study finds it is safe for patients who undergo heart stent procedures to quit taking aspirin at 3 months so long as they continue taking a P2Y12 inhibitor.

How and when do you decide whether to prescribe a patient GLP1 agonists or SGLT2 inhibitors?

What are some of the future risks, in terms of cardiovascular health, facing the average patient?

Insight regarding the recent change to aspirin guidelines and what it means for patients from platelet specialist Jeffrey Berger, MD.

The oral tablet generics approvals also come with 2 approved shared system REMS programs for ambrisentan.

Barbhaiya talks about what he considers to be misleading success rates for Afib ablation being published in studies.

Discussing the implications and future of wearable technology after the release of the Apple Heart Study.

The application to the FDA for icosapent ethyl seeks a new indication to reduce the risk of major adverse cardiovascular events.

MD Magazine sat down with Chirag Barbhaiya, MD, of NYU Langone Health, to discuss the updated guidelines for treating a patient with Afib.

A study of patients recommended for statin therapy under ACC/AHA guidelines, but not taking any, found that 59.2% reported never being offered a statin.

A new cohort assessment shows white and African American men both have a lifetime hypertension risk of more than 80%.

Investigators observed a 22% and 20% increased risk of heart failure during the 2 most severe influenza seasons.

A short account of patients I’ve known and not loved over the years.

A 52-year-old female with a history of breast cancer is sent to the ED by her oncologist for a mild headache that's lasted 10 days. What does the EKG show?

The American College of Cardiology and the American Heart Association have updated treatment recommendations for the primary prevention of cardiovascular disease. Among the recommendations:  Stop recommending aspirin to prevent CVD.

No significant differences in cardiovascular outcomes among patients receiving different GLP-1 agonists including exenatide extended-release, exenatide immediate-release, liraglutide, albiglutide, and dulaglutide.

How the PIONEER-HF and PARADIGM-HF trials have focused on varied, but realistic heart failure patients.

A year-long outpatient care study showed that patients with type 2 diabetes and comorbid cardiovascular disease are 5 times as likely to visit a cardiologist.

It's been 4 years since the drug class reached the market. Are patients adhering to the therapy, and what more potential does it have?